NCT05288166: A Study of Abemaciclib (LY2835219) With Abiraterone in Men With Prostate Cancer That Has Spread to Other Parts of the Body and is Expected to Respond to Hormonal Treatment (Metastatic Hormone-Sensitive Prostate Cancer)
- State
- Under way
- Phase
- Phase 3
- People
- 925 taking part
- Started
- 14 Apr 2022
- Primary completion
- 15 Feb 2024
- Arms
- Abemaciclib
- Results
- Posted on the registry
- 21 Mar 2022: Trial registered
- 14 Apr 2022: Trial started
- 27 Jun 2025: Trial results posted